Related Articles
Fungal mannosylation enhances human papillomavirus 16 E7 therapeutic immunity against TC-1 tumors
Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16.
Therapy of HPV 16-associated carcinoma with dendritic cell-based vaccines: in vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide.
Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A
The pro-angiogenic factors stimulated by human papillomavirus type 16 E6 and E7 protein in C33A and human fibroblasts